Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,774 public trials 499 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803 in Patients With Advanced Solid Tumors

NCT01946789

Conditions
Advanced Solid Tumors, Melanoma, Neoplasm Metastasis, +14 more
Locations
  • University of Minnesota Minneapolis, Minnesota, United States
  • Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
View Trial Details
Completed

CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)

NCT03504488

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +24 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope - Duarte Duarte, California, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • California Research Institute Los Angeles, California, United States
View all 59 locations
View Trial Details
Completed

Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer

NCT01902173

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +25 more
Locations
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • California Pacific Medical Center-Pacific Campus San Francisco, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
View all 16 locations
View Trial Details
Completed

UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma

NCT04382664

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • University of California Irvine Health Orange, California, United States
  • California Cancer Associates for Research & Excellence (CCARE San Marcos, California, United States
View all 37 locations
View Trial Details
Completed

Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer

NCT04121676

Conditions
Advanced Cancer, Melanoma, Neoplasms, +10 more
Locations
  • University of Southern California Norris Comprehensive Cancer Center/ Hoag Los Angeles, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • University of Miami Coral Gables, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details

Related conditions